It is a healthcare private limited company based in Patna, Bihar, India, established in 2012.
2012 | Patna, Bihar, India | ActiveConsole Lifesciences Private Limited, a active private limited company, was established on 23 July 2012 in Patna, Bihar, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U24232BR2012PTC018971. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹8.00 M and a paid-up capital of ₹8.00 M.
Formerly known as Concept Life Science Private Limited. It upholds a compliant status. Its leadership includes Amit Kumar Singh (Director), Vidya Sagar (Director), Uma Shankar (Managing Director). Past directors included Shiva Shankar, Mohammad Faizur Rahman, Khurshid Alam Khan. It holds ₹4.10 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 4H/32, Bahadurpur Housing Colony,Bhoothnath Road Agamkuan, Patna, Bihar, 800026.
U24232BR2012PTC018971
018971
23 July 2012
₹8.00 M
₹8.00 M
Roc Patna
Unlisted
Active
Explore comprehensive insights into Console Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amit Kumar Singh | Director | 23 Jul 2012 | Current |
| Vidya Sagar | Director | 23 Jul 2012 | Current |
| Uma Shankar | Managing Director | 23 Jul 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Dec 2014 | Past |
| Pramod Abcsdd | Director | 20 Dec 2014 | Past |
| Pramod Abcsdd | Director | 20 Dec 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Console Lifesciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 20.47% decrease. The company also saw a substantial fall in profitability, with a 28.97% decrease in profit. The company's net worth moved up by a moderate rise of 8.11%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Console Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹41,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jun 2020 | Canara Bank | ₹6.00 M | Open |
| 23 Dec 2019 | Canara Bank | ₹5.00 M | Open |
| 30 Jan 2015 | Canara Bank | ₹3.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Console Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Console Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Console Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Console Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Console Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Patna. was documented.
A charge with Canara Bank amounted to Rs. 6.00 M with Charge ID 100341211 was registered on 18 Jun 2020. was recorded as a recent event.
A charge with Canara Bank amounted to Rs. 5.00 M with Charge ID 100309572 was registered on 23 Dec 2019. was recorded as a recent event.
A charge with Canara Bank of Rs. 30.00 M registered on 30 Jan 2015 with Charge ID 10558699 was modified on 05 Jan 2018. was recorded as a recent event.
Progress on A charge with Canara Bank amounted to Rs. 30.00 M with Charge ID 10558699 was registered on 30 Jan 2015. was documented.
The CIN of Console Lifesciences Private Limited is U24232BR2012PTC018971.
Console Lifesciences Private Limited is headquartered at 4H/32, Bahadurpur Housing Colony,Bhoothnath Road Agamkuan, Patna, Bihar, 800026.
Console Lifesciences Private Limited was incorporated on 23 July 2012.
The current directors of Console Lifesciences Private Limited are
The primary industry of Console Lifesciences Private Limited is Trade.
Console Lifesciences Private Limited is unlisted.
The authorized capital of Console Lifesciences Private Limited is ₹8.00 M, and the paid-up capital is ₹8.00 M.
The compliance status of Console Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX